Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice

被引:132
作者
Guthrie, Liam M. [1 ]
Soma, Shivatheja [2 ]
Yuan, Sai [3 ]
Silva, Andres [2 ]
Zulkifli, Mohammad [2 ]
Snavely, Thomas C. [2 ]
Greene, Hannah Faith [2 ]
Nunez, Elyssa [2 ]
Lynch, Brogan [2 ]
De Ville, Courtney [2 ]
Shanbhag, Vinit [4 ]
Lopez, Franklin R. [5 ,6 ]
Acharya, Arjun [2 ]
Petris, Michael J. [4 ]
Kim, Byung-Eun [3 ]
Gohil, Vishal M. [2 ]
Sacchettini, James C. [2 ]
机构
[1] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA
[2] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA
[3] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA
[4] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA
[5] Texas Vet Med Diagnost Labs, College Stn, TX 77843 USA
[6] Charles River Labs, Durham, NC 27703 USA
基金
美国国家卫生研究院;
关键词
COPPER TRANSPORT; OXIDASE DEFICIENCY; DRUG ELESCLOMOL; MURINE MODEL; DISEASE; MUTATIONS; BRAIN; ACQUISITION; MECHANISMS; OUTCOMES;
D O I
10.1126/science.aaz8899
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Loss-of-function mutations in the copper (Cu) transporter ATP7A cause Menkes disease. Menkes is an infantile, fatal, hereditary copper-deficiency disorder that is characterized by progressive neurological injury culminating in death, typically by 3 years of age. Severe copper deficiency leads to multiple pathologies, including impaired energy generation caused by cytochrome c oxidase dysfunction in the mitochondria. Here we report that the small molecule elesclomol escorted copper to the mitochondria and increased cytochrome c oxidase levels in the brain. Through this mechanism, elesclomol prevented detrimental neurodegenerative changes and improved the survival of the mottled-brindled mouse-a murine model of severe Menkes disease. Thus, elesclomol holds promise for the treatment of Menkes and associated disorders of hereditary copper deficiency.
引用
收藏
页码:620 / +
页数:52
相关论文
共 33 条
[1]   Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol [J].
Blackman, Ronald K. ;
Cheung-Ong, Kahlin ;
Gebbia, Marinella ;
Proia, David A. ;
He, Suqin ;
Kepros, Jane ;
Jonneaux, Aurelie ;
Marchetti, Philippe ;
Kluza, Jerome ;
Rao, Patricia E. ;
Wada, Yumiko ;
Giaever, Guri ;
Nislow, Corey .
PLOS ONE, 2012, 7 (01)
[2]   A CMC1-knockout reveals translation-independent control of human mitochondrial complex IV biogenesis [J].
Bourens, Myriam ;
Barrientos, Antoni .
EMBO REPORTS, 2017, 18 (03) :477-494
[3]   Copper transport to the brain by the blood-brain barrier and blood-CSF barrier [J].
Choi, Byuny-Sun ;
Zheng, Wei .
BRAIN RESEARCH, 2009, 1248 :14-21
[4]   ATP7A Gene Addition to the Choroid Plexus Results in Long-term Rescue of the Lethal Copper Transport Defect in a Menkes Disease Mouse Model [J].
Donsante, Anthony ;
Yi, Ling ;
Zerfas, Patricia M. ;
Brinster, Lauren R. ;
Sullivan, Patricia ;
Goldstein, David S. ;
Prohaska, Joseph ;
Centeno, Jose A. ;
Rushing, Elisabeth ;
Kaler, Stephen G. .
MOLECULAR THERAPY, 2011, 19 (12) :2114-2123
[5]   Copper: toxicological relevance and mechanisms [J].
Gaetke, Lisa M. ;
Chow-Johnson, Hannah S. ;
Chow, Ching K. .
ARCHIVES OF TOXICOLOGY, 2014, 88 (11) :1929-1938
[6]   A direct comparison of divalent metal-ion transporter (DMT1) and hinokitiol, a potential small molecule replacement [J].
Garrick, Michael D. ;
Garrick, Laura M. ;
Zhao, Lin ;
Collins, James F. ;
Soukup, Joleen ;
Ghio, Andrew J. .
BIOMETALS, 2019, 32 (05) :745-755
[7]  
Gillespie J M, 1973, Australas J Dermatol, V14, P127, DOI 10.1111/j.1440-0960.1973.tb01208.x
[8]   Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals [J].
Grillo, Anthony S. ;
SantaMaria, Anna M. ;
Kafina, Martin D. ;
Cioffi, Alexander G. ;
Huston, Nicholas C. ;
Han, Murui ;
Seo, Young Ah ;
Yien, Yvette Y. ;
Nardone, Christopher ;
Menon, Archita V. ;
Fan, James ;
Svoboda, Dillon C. ;
Anderson, Jacob B. ;
Hong, John D. ;
Nicolau, Bruno G. ;
Subedi, Kiran ;
Gewirth, Andrew A. ;
Wessling-Resnick, Marianne ;
Kim, Jonghan ;
Paw, Barry H. ;
Burke, Martin D. .
SCIENCE, 2017, 356 (6338) :608-616
[9]   Molecular basis of the brindled mouse mutant (Mo-br): A murine model of Menkes disease [J].
Grimes, A ;
Hearn, CJ ;
Lockhart, P ;
Newgreen, DF ;
Mercer, JFB .
HUMAN MOLECULAR GENETICS, 1997, 6 (07) :1037-1042
[10]   Cerebrospinal Fluid-Directed rAAV9-rsATP7A Plus Subcutaneous Copper Histidinate Advance Survival and Outcomes in a Menkes Disease Mouse Model [J].
Haddad, Marie Reine ;
Choi, Eun-Young ;
Zerfas, Patricia M. ;
Yi, Ling ;
Martinelli, Diego ;
Sullivan, Patricia ;
Goldstein, David S. ;
Centeno, Jose A. ;
Brinster, Lauren R. ;
Ralle, Martina ;
Kaler, Stephen G. .
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 10 :165-178